A Bright Future for Psychedelics Under Trump?

November 13, 2024

Lykos, FDA Discuss Phase 3 MDMA Trial Plans

October 20, 2024

Lykos Therapeutics Shakeup Continues With Leadership Change

September 6, 2024

Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead

June 7, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024